ArticleIndian journal of palliative care
Neurolysis of the Sphenopalatine Ganglion for Refractory Facial Pain in a Paediatric Cancer Patient: A Case Report.
Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Simulation of suprazygomatic and infrazygomatic approaches for maxillary nerve block in children.Journal of anesthesia · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial pain associated with oncologic pathologies in pediatric patients presents significant diagnostic and therapeutic challenges with a considerable impact on quality of life. In this context, chemical neurolysis of the sphenopalatine ganglion emerges as a promising therapeutic option. We present the case of a 9-year-old girl with embryonal rhabdomyosarcoma who experienced severe facial pain resistant to conventional treatment. The pain was described as continuous, disabling, and neuropathic in nature, affecting basic functions such as eating and sleeping. Pharmacological management with opioids and adjuvants was insufficient, with high opioid requirements and minimal relief. A diagnostic sphenopalatine ganglion block was performed using a transnasal approach, yielding temporary but complete analgesia. Based on this response, percutaneous chemical neurolysis via the infrazygomatic route was carried out under fluoroscopic guidance using absolute alcohol. Following the intervention, pain intensity decreased from 10/10 to 4/10 at 24 hours and to 0/10 at 7 days, with sustained complete pain relief at 3-month follow-up. This was accompanied by a substantial improvement in quality of life and complete discontinuation of opioid use. No complications were observed during or after the procedure. This case highlights the efficacy and safety of chemical neurolysis of the sphenopalatine ganglion as an innovative therapeutic option for refractory facial pain in pediatric patients with head and neck oncologic diseases, particularly when conventional measures fail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.